anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Valneva · pitchdeck

Valneva | IPO Presentation Deck | 41 slides

41 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Valneva | IPO Presentation Deck | 41 slides

Valneva · 2021-04
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 5 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Traction 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
100% 2/2 slides
— 0/2 slides
100% 2/2 slides
— 0/2 slides
Business Model 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

41
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
state_next_steps
Open slide detail
04
The slide uses a grid layout to display five executives with their respective headshots, titles, brief bios, and logos of previous companies.other
Open slide detail
05
summarize
Open slide detail
06
The slide uses a Gantt-style visualization to map programs against development phases.plan_implementation
Open slide detail
07
The slide uses a callout box to zoom into European operations from a global map.establish_context
Open slide detail
08
front_matter
Open slide detail
09
Includes a geographic map showing the spread of Lyme disease over time (2001-2015).frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
The slide uses a numbered list format to highlight five key value propositions.summarize
Open slide detailBeat · SolutionLoop · Cost Of Inaction
11
The slide uses a process flow framework to explain the biological mechanism of action.present_solution
Open slide detailLoop · Cost Of Inaction
12
The chart compares baseline, post-primary, and post-booster levels. The y-axis is logarithmic.show_traction
Open slide detailBeat · Traction
13
The chart shows high efficacy for the treatment groups compared to the placebo, with no significant difference between the two dosage levels.show_traction
Open slide detailBeat · Traction
14
plan_implementation
Open slide detail
15
show_traction
Open slide detail
16
transition
Open slide detail
17
Includes footnote citations for data points.frame_problem
Open slide detail
18
The slide uses a numbered list format to present key milestones and competitive advantages.show_traction
Open slide detail
19
The slide uses a Gantt-style timeline to illustrate clinical trial phases and patient cohorts.plan_implementation
Open slide detail
20
The chart uses a logarithmic scale on the y-axis to display antibody titers.show_traction
Open slide detail
21
The charts show a significant reduction in adverse events (AEs) after re-vaccination compared to single vaccination.analyze_data
Open slide detail
22
The slide uses a two-column layout to contrast immunogenicity and safety outcomes.show_traction
Open slide detail
23
Includes specific trial identifiers (VLA1553-302, VLA1553-303) and participant counts.plan_implementation
Open slide detail
24
front_matter
Open slide detail
25
present_solution
Open slide detail
26
The slide uses a numbered list format to highlight progress, including financial, manufacturing, partnership, clinical, and regulatory milestones.show_traction
Open slide detail
27
Includes two grouped bar charts comparing side effect frequencies across low, medium, and high dose groups.show_traction
Open slide detail
28
Includes specific clinical trial data references (Table 14.3.5.1, 14.3.6.1).show_traction
Open slide detail
29
Includes statistical analysis of antibody titers across different dose groups over time.show_traction
Open slide detail
30
The plot includes a legend for visit days and indicates limits of detection with red dashed lines.analyze_data
Open slide detail
31
Data presented as percentages and raw counts for reactive participants.analyze_data
Open slide detail
32
plan_implementation
Open slide detail
33
The slide highlights a major commercial partnership and government funding support.show_traction
Open slide detail
34
transition
Open slide detail
35
The slide highlights the dual nature of the business: commercial travel vaccines and government contracting.present_solution
Open slide detailBeat · Business Model
36
transition
Open slide detail
37
plan_implementation
Open slide detailLoop · Why Now
38
transition
Open slide detailLoop · Why Now
39
plan_implementation
Open slide detailLoop · Why Now
40
transition
Open slide detail
41
state_next_steps
Open slide detail